398 related articles for article (PubMed ID: 29803225)
41. Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease.
Yasuda T; Hayakawa H; Nihira T; Ren YR; Nakata Y; Nagai M; Hattori N; Miyake K; Takada M; Shimada T; Mizuno Y; Mochizuki H
J Neuropathol Exp Neurol; 2011 Aug; 70(8):686-97. PubMed ID: 21760537
[TBL] [Abstract][Full Text] [Related]
42. Running promotes spatial bias independently of adult neurogenesis.
Snyder JS; Cahill SP; Frankland PW
Hippocampus; 2017 Aug; 27(8):871-882. PubMed ID: 28474795
[TBL] [Abstract][Full Text] [Related]
43. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
[TBL] [Abstract][Full Text] [Related]
44. CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's disease.
Noelker C; Stuckenholz V; Reese JP; Alvarez-Fischer D; Sankowski R; Rausch T; Oertel WH; Hartmann A; van Patten S; Al-Abed Y; Bacher M
Neurodegener Dis; 2013; 12(2):103-10. PubMed ID: 23147695
[TBL] [Abstract][Full Text] [Related]
45. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease.
Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y
Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210
[TBL] [Abstract][Full Text] [Related]
46. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
[TBL] [Abstract][Full Text] [Related]
47. Mice with conditional NeuroD1 knockout display reduced aberrant hippocampal neurogenesis but no change in epileptic seizures.
Brulet R; Zhu J; Aktar M; Hsieh J; Cho KO
Exp Neurol; 2017 Jul; 293():190-198. PubMed ID: 28427858
[TBL] [Abstract][Full Text] [Related]
48. Serotonin 5-HT
Ishii T; Kinoshita KI; Muroi Y
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717815
[TBL] [Abstract][Full Text] [Related]
49. Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease.
Ding W; Lin H; Hong X; Ji D; Wu F
Toxicology; 2020 Apr; 436():152437. PubMed ID: 32169474
[TBL] [Abstract][Full Text] [Related]
50. The majority of newly generated cells in the adult mouse substantia nigra express low levels of Doublecortin, but their proliferation is unaffected by 6-OHDA-induced nigral lesion or Minocycline-mediated inhibition of neuroinflammation.
Worlitzer MM; Viel T; Jacobs AH; Schwamborn JC
Eur J Neurosci; 2013 Sep; 38(5):2684-92. PubMed ID: 23734736
[TBL] [Abstract][Full Text] [Related]
51. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
[TBL] [Abstract][Full Text] [Related]
52. Ceftriaxone prevents the neurodegeneration and decreased neurogenesis seen in a Parkinson's disease rat model: An immunohistochemical and MRI study.
Weng JC; Tikhonova MA; Chen JH; Shen MS; Meng WY; Chang YT; Chen KH; Liang KC; Hung CS; Amstislavskaya TG; Ho YJ
Behav Brain Res; 2016 May; 305():126-39. PubMed ID: 26940602
[TBL] [Abstract][Full Text] [Related]
53. Ablation of proliferating neural stem cells during early life is sufficient to reduce adult hippocampal neurogenesis.
Youssef M; Krish VS; Kirshenbaum GS; Atsak P; Lass TJ; Lieberman SR; Leonardo ED; Dranovsky A
Hippocampus; 2018 Aug; 28(8):586-601. PubMed ID: 29742815
[TBL] [Abstract][Full Text] [Related]
54. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
[TBL] [Abstract][Full Text] [Related]
55. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
56. Anti-inflammatory and anti-apoptotic effects of (RS)-glucoraphanin bioactivated with myrosinase in murine sub-acute and acute MPTP-induced Parkinson's disease.
Galuppo M; Iori R; De Nicola GR; Bramanti P; Mazzon E
Bioorg Med Chem; 2013 Sep; 21(17):5532-47. PubMed ID: 23810671
[TBL] [Abstract][Full Text] [Related]
57. Enhanced dopaminergic neurotoxicity mediated by MPTP in IL-32β transgenic mice.
Jung YY; Katila N; Neupane S; Shadfar S; Ojha U; Bhurtel S; Srivastav S; Son DJ; Park PH; Yoon DY; Hong JT; Choi DY
Neurochem Int; 2017 Jan; 102():79-88. PubMed ID: 27956238
[TBL] [Abstract][Full Text] [Related]
58. Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice.
Wang L; Zhai YQ; Xu LL; Qiao C; Sun XL; Ding JH; Lu M; Hu G
Exp Neurol; 2014 Jan; 251():22-9. PubMed ID: 24220636
[TBL] [Abstract][Full Text] [Related]
59. Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways.
Cao Q; Qin L; Huang F; Wang X; Yang L; Shi H; Wu H; Zhang B; Chen Z; Wu X
Toxicol Appl Pharmacol; 2017 Mar; 319():80-90. PubMed ID: 28185818
[TBL] [Abstract][Full Text] [Related]
60. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
Lee Y; Park HR; Chun HJ; Lee J
J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
